×

Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength

  • US 6,306,844 B1
  • Filed: 07/14/2000
  • Issued: 10/23/2001
  • Est. Priority Date: 03/17/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating metabolic bone disease to maintain or increase bone mass comprising administering to a patient with said disease an effective amount of 2α

  • -methyl-19-nor-20(S)-1α

    ,25-dihydroxyvitamin D3 having the formula;

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×